Variant · Snv
CDKN2A P81T
CI-VAR-00003413Explore in graph →NP_000068.1:p.Pro81ThrNM_000077.5:c.241C>AClinVar 629992 CIViC 3384
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 19260062
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Unmapped disease1unmapped disease | ||||||||
| CDKN2A P81T | (functional) | Functional | D | Supports Loss Of Function | 3 | submitted | EID9424Melanoma-associated germline CDKN2A mutations were assessed for functional effects. Amino acid conservation between human and nine other species showed that proline 81 is highly conserved and changes … (full text at CIViC) PMID 19260062 · Kannengiesser et al., 2009 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available